PCYC reversal is following through very nicely as it comes out of oversold territory. Got lucky and managed to call bottom two days ago with my original post on 12/18.
Key points of resistance/support shown above. Looking for the reversal to continue towards the long-term trend-line around $132.
$PCYC is showing a nice reversal as it fights to get through resistance just below $102. Nice fat green candlestick forming today, yesterday would have been a nice entry point if you were following my original post on this. Watch for follow through over the next couple of days and a cross over the $103.26 point where the 200 day MA meets a long-term support...
Strong uptrend in PCYC recently broken and beaten down to well below the average analyst price target of $146. Pharmacyclics is a clinical stage biotech stock that recently got approval of its drug Ibrutinib, a cancer treatment drug. Their drug has had very successful results and are setup to have a very strong first quarter earnings next year. Despite the...
